On Friday, the FDA approved Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA’s (NASDAQ:SNY) Dupixent (dupilumab) ...
The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...
New schizophrenia drug ‘could change the lives of millions of people’ - The US Food and Drug Administration has approved ...
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.
Lawmakers passed a law designed to limit reproductive rights in Louisiana. But it may also limit patients’ chances of ...
Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...
The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...
While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.
The Food and Drug Administration is expected to approve the first new type of drug for schizophrenia in decades. Called KarXT, the medicine appears to be effective, but its main advantage over current ...